Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPRENORPHINE Cause Benign prostatic hyperplasia? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Benign prostatic hyperplasia have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.0% of all adverse event reports for BUPRENORPHINE.

5
Reports of Benign prostatic hyperplasia with BUPRENORPHINE
0.0%
of all BUPRENORPHINE reports
2
Deaths
3
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From BUPRENORPHINE?

Of the 5 reports, 2 (40.0%) resulted in death, 3 (60.0%) required hospitalization.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does BUPRENORPHINE Cause?

Drug dependence (16,730) Overdose (13,977) Death (13,604) Toxicity to various agents (10,906) Pain (8,219) Drug withdrawal syndrome (7,149) Emotional distress (6,159) Drug abuse (4,344) Drug ineffective (4,261) Dependence (3,184)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which BUPRENORPHINE Alternatives Have Lower Benign prostatic hyperplasia Risk?

BUPRENORPHINE vs BUPRENORPHINE\NALOXONE BUPRENORPHINE vs BUPROPION BUPRENORPHINE vs BUPROPION HYDROBROMIDE BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPRENORPHINE vs BUPROPION\NALTREXONE

Related Pages

BUPRENORPHINE Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia BUPRENORPHINE Demographics